125 related articles for article (PubMed ID: 17277625)
1. Effects of halofuginone on fibrosis formation secondary to experimentally induced subglottic trauma.
Ertuğrul EE; Cincik H; Dogru S; Cekin E; Berber U; Gungor A; Poyrazoğlu IE
Laryngoscope; 2007 Feb; 117(2):299-302. PubMed ID: 17277625
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of topically applied halofuginone in management of subglottic stenosis in rats.
Ertuğrul EE; Cekin IE; Cincik H; Doğru S; Güngör A
Otolaryngol Head Neck Surg; 2009 May; 140(5):720-3. PubMed ID: 19393418
[TBL] [Abstract][Full Text] [Related]
3. The preventive effect of halofuginone on posterior glottic stenosis in a rabbit model.
Yoon YH; Rha KS; Koo BS; Park JY; Kim YM; Park YH
Otolaryngol Head Neck Surg; 2008 Jul; 139(1):94-9. PubMed ID: 18585568
[TBL] [Abstract][Full Text] [Related]
4. The effect of halofuginone, a specific inhibitor of collagen type 1 synthesis, in the prevention of esophageal strictures related to caustic injury.
Ozçelik MF; Pekmezci S; Saribeyoğlu K; Unal E; Gümüştaş K; Doğusoy G
Am J Surg; 2004 Feb; 187(2):257-60. PubMed ID: 14769315
[TBL] [Abstract][Full Text] [Related]
5. Potential therapeutical effects of topical halofuginone hydrobromide in keloid management.
Lista S; Emanuele E
Med Hypotheses; 2007; 69(3):707. PubMed ID: 17331662
[No Abstract] [Full Text] [Related]
6. Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention.
Zion O; Genin O; Kawada N; Yoshizato K; Roffe S; Nagler A; Iovanna JL; Halevy O; Pines M
Pancreas; 2009 May; 38(4):427-35. PubMed ID: 19188864
[TBL] [Abstract][Full Text] [Related]
7. The effect of halofuginone, a specific inhibitor of collagen type 1 synthesis, in the prevention of pancreatic fibrosis in an experimental model of severe hyperstimulation and obstruction pancreatitis.
Karatas A; Paksoy M; Erzin Y; Carkman S; Gonenc M; Ayan F; Aydogan F; Uzun H; Durak H
J Surg Res; 2008 Jul; 148(1):7-12. PubMed ID: 18570924
[TBL] [Abstract][Full Text] [Related]
8. The effect of halofuginone, an inhibitor of collagen type i synthesis, on urethral stricture formation: in vivo and in vitro study in a rat model.
Nagler A; Gofrit O; Ohana M; Pode D; Genina O; Pines M
J Urol; 2000 Nov; 164(5):1776-80. PubMed ID: 11025768
[TBL] [Abstract][Full Text] [Related]
9. Halofuginone prevents subglottic stenosis in a canine model.
Eliashar R; Ochana M; Maly B; Pines M; Sichel JY; Nagler A
Ann Otol Rhinol Laryngol; 2006 May; 115(5):382-6. PubMed ID: 16739671
[TBL] [Abstract][Full Text] [Related]
10. The effects of mitomycin C and 5-fluorouracil/triamcinolone on fibrosis/scar tissue formation secondary to subglottic trauma (experimental study).
Cincik H; Gungor A; Cakmak A; Omeroglu A; Poyrazoglu E; Yildirim S; Cekin E; Candan H
Am J Otolaryngol; 2005; 26(1):45-50. PubMed ID: 15635581
[TBL] [Abstract][Full Text] [Related]
11. Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone.
Turgeman T; Hagai Y; Huebner K; Jassal DS; Anderson JE; Genin O; Nagler A; Halevy O; Pines M
Neuromuscul Disord; 2008 Nov; 18(11):857-68. PubMed ID: 18672370
[TBL] [Abstract][Full Text] [Related]
12. Halofuginone, a specific inhibitor of collagen type 1 synthesis, ameliorates oxidant colonic damage in rats with experimental colitis.
Karakoyun B; Yüksel M; Ercan F; Salva E; Işik I; Yeğen BC
Dig Dis Sci; 2010 Mar; 55(3):607-16. PubMed ID: 19390970
[TBL] [Abstract][Full Text] [Related]
13. Halofuginone inhibits collagen deposition in fibrous capsules around implants.
Olbrich KC; Meade R; Bruno W; Heller L; Klitzman B; Levin LS
Ann Plast Surg; 2005 Mar; 54(3):293-6;discussion 296. PubMed ID: 15725837
[TBL] [Abstract][Full Text] [Related]
14. Halofuginone reduces the occurrence of renal fibrosis in 5/6 nephrectomized rats.
Benchetrit S; Yarkoni S; Rathaus M; Pines M; Rashid G; Bernheim J; Bernheim J
Isr Med Assoc J; 2007 Jan; 9(1):30-4. PubMed ID: 17274353
[TBL] [Abstract][Full Text] [Related]
15. Is there any synergic effect for coadministration of mitomycin C and halofuginone on the skin wound healing?
Yoon YH; Rha KS; Kim DH; Kim EH; Kim JM; Koo BS
Am J Otolaryngol; 2011; 32(2):130-4. PubMed ID: 20392524
[TBL] [Abstract][Full Text] [Related]
16. The use of halofuginone in limiting urethral stricture formation and recurrence: an experimental study in rabbits.
Jaidane M; Ali-El-Dein B; Ounaies A; Hafez AT; Mohsen T; Bazeed M
J Urol; 2003 Nov; 170(5):2049-52. PubMed ID: 14532851
[TBL] [Abstract][Full Text] [Related]
17. Surface modification of silicone breast implants by binding the antifibrotic drug halofuginone reduces capsular fibrosis.
Zeplin PH; Larena-Avellaneda A; Schmidt K
Plast Reconstr Surg; 2010 Jul; 126(1):266-274. PubMed ID: 20595874
[TBL] [Abstract][Full Text] [Related]
18. Reduction of burn scar formation by halofuginone-eluting silicone gel sheets: a controlled study on nude mice.
Zeplin PH
Ann Plast Surg; 2012 Mar; 68(3):271-5. PubMed ID: 22356780
[TBL] [Abstract][Full Text] [Related]
19. Effect of intraurethral Mitomycin-C on healing and fibrosis in rats with experimentally induced urethral stricture.
Ayyildiz A; Nuhoglu B; Gülerkaya B; Caydere M; Ustün H; Germiyanoglu C; Erol D
Int J Urol; 2004 Dec; 11(12):1122-6. PubMed ID: 15663686
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of muscle fibrosis and improvement of muscle histopathology in dysferlin knock-out mice treated with halofuginone.
Halevy O; Genin O; Barzilai-Tutsch H; Pima Y; Levi O; Moshe I; Pines M
Histol Histopathol; 2013 Feb; 28(2):211-26. PubMed ID: 23275304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
